The aim of the study by Dorota Purzycka-Bohdan et al. was to investigate whether the serum levels of IL-16 and the cutaneous mRNA expression of IL-16 (messenger RNA) correlate with the clinical severity of psoriasis and the cutaneous mRNA expression of CD4. The gene discussed is IL16; the disease is psoriasis.